TABLE 3.
FINAL MULTIVARIABLE COX PROPORTIONAL HAZARD MODEL
| Exposure | CKD Hazard Ratio (95% CI) |
| Acute pulmonary exacerbations* | |
| No exacerbations | REF |
| One to five exacerbations | 0.79 (0.56–1.11) |
| Six to nine exacerbations | 0.92 (0.58–1.46) |
| ≥ 10 exacerbations | 1.16 (0.75–1.81) |
| CFRD (insulin-requiring)* | |
| 0 yr | REF |
| 1–4 yr | 2.40 (1.74–3.32) |
| ≥ 5 yr | 4.56 (2.85–7.28) |
| Per additional year of age | 1.11 (1.10–1.12) |
| Per additional year of inhaled tobramycin use | 0.89 (0.81–0.97) |
| Per unit increase in BMI, kg/m2 | 0.86 (0.82–0.90) |
Definition of abbreviations: BMI = body mass index; CFRD = cystic fibrosis–related diabetes; CI = confidence interval; CKD = chronic kidney disease.
Includes exposure up to 3 years before cohort entry.